Cidara Therapeutics, Inc. (CDTX)

220.65 +0.46 (+0.21%) USD  |  NASDAQ  |  Dec 12, 16:00
220.65 0.00 (0.00%) After-Hours: 20:00
More

Cidara Therapeutics Gross Profit (Annual): 1.042M for Dec. 31, 2024

Gross Profit (Annual) Chart

View Gross Profit (Annual) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Merck & Co., Inc. 47.17B
Mersana Therapeutics, Inc. 38.87M
Bristol Myers Squibb Co. 27.43B
Johnson & Johnson 60.96B
Pfizer Inc. 41.85B